A multi-entrepreneur for more than 13 years, Christophe SICOT works in line with market trends, particularly in well-being, health, and fashion. The recent launch of the consulting agency, “CS Agency,” shows his aspiration to share a compelling urge for disruption and innovation. This initiative comes at a period when the concept of entrepreneurship faces scrutiny amid economic and geopolitical uncertainties.
For example, VERSO HEALTHCARE, since its inception in 2010, embodied the DNA of its founder. It had a pioneering position in the financing of medical equipment and technical platforms, followed by the deployment of business and geographical subsidiaries.
The establishment of MANAYA centers in 2020 aimed to bridge the worlds of medicine and well-being, often seen as antagonistic yet deeply interconnected, as both physical and psychological aspects contribute to well-being and aid in healing.
In December 2021, Christophe founded the company and brand 12IA, going against conventional positioning and investments, convinced of the strength of an innovative and responsible European and French textile sector. This also reflects a societal approach, as art and creation are more than ever seen as values of humanity.
Meanings of True Success
Christophe believes that success is driven by values and the people one encounters, including family, colleagues, clients, or partners. His experience in founding, acquiring, integrating, developing, and managing companies across different economic sectors has been rewarding. In 2020, he founded 123CS, a company focused on cybersecurity and health data hosting, amid the peak of the health crisis. Currently, he heads this company, recognizing its remarkable growth and potential within his entrepreneurial portfolio. It’s a somewhat unconventional but triumphant gamble, evident in the company’s progress and promising outlook, both domestically and internationally.
Insights on Tech Development in Health Sector
According to Christophe, health data has become a focal point in recent discussions and initiatives, especially with the rise of digital medicine, electronic medical records, and data-driven health research. It’s a valuable asset evident in the increasing cyberattacks targeting the sector.
Recognizing this, 123CS acknowledges that health data, covering its creation, storage, management, and use, forms the foundation of a more preventive, equitable, efficient, and economically accessible medicine—a more sustainable approach.
The company aimed to provide solutions that are not only indisputably secure but also accessible to all stakeholders, ranging from independent doctors to university hospitals.
Health data is owned by patients, healthcare providers, public and governmental health organizations, as well as economic players and third parties. Shifting from viewing it primarily as an IT asset, it should be regarded as a valuable asset deserving protection and insurance.
This realization guided the creation of 123CS, where emphasis was placed on expertise and the legitimacy of their position. The priority was to gather recognized expertise from the public, private, and especially the health sector.
A Goal Oriented Team
Christophe expresses gratitude to his team for the swift attainment of recognition, evident in certifications (ISO 27001 and HDS), labels (Expert Cyber and France Cyber Security), commitments (cybermalveillance.gouv.fr, SecNumedu, ANSSI Security Visa), and partnerships (ACN, Apssis, SGDSN). The pursuit of PASSI RGS (ANSSI) and SECNUMCLOUD (ANSSI) certifications is also underway.
The company was determined to present a fresh economic model, believing in the viability of its solutions for clients. Subscription-based offers, resembling insurance models, assure a high level of service, allowing clients to terminate at any time. This approach ensures that clients consistently receive responses in line with market standards and regulatory and technological advancements.
With a focus on the healthcare sector, certified solutions, esteemed collaborators, and an inclusive economic model, the company has secured success and a distinctive market position. Known for its responsiveness and profound understanding of the medical field, the company operates in regions such as France, Switzerland, Benelux, Italy, and Spain, serving nearly 8,000 clients.
Vision for Future
Christophe vision for 123CS, both nationally and internationally. The robust development since 2020 reinforces human and technological orientations.
In 2024, the focus will be on:
- Continually adding more value to clients with simple and immediately operational solutions.
- Continuing to innovate to adapt solutions to rapid changes in the healthcare sector, forming partnerships with existing players and innovative startups.
- Deploying solutions with clients, combining reciprocal expertise, making them actors in their security.
Success, as per Christophe’s experience, relies on close collaboration and a shared vision among the leader, teams, clients, and partners. In recent years, 4P medicine—personalized, preventive, predictive, and participativehas emerged, representing a shift towards a holistic and hopeful approach for many pathologies.
This approach aligns with 123CS’s strategy: 4P solutions—personalized, preventive, predictive, and participative. These, perhaps, are the keys to a company’s success and advice he could offer to a leader.
Christophe states that the success of a company and its leader depends on a clear vision, a solid business plan, market knowledge, a quality product or service, innovation to some extent, a competent and enduring team, effective management, customer satisfaction, a marketing strategy, and especially strong agility and adaptability.
